ArticleESMO gastrointestinal oncology2026
Comparative outcomes with low-dose and standard-dose immune checkpoint inhibitors in microsatellite stable advanced gastric/gastroesophageal adenocarcinoma.
A Ramaswamy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.